With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India Medical Dialogues Bureau9 April 2020 7:00 AMNew Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative...
Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 6:45 AMVenclexta/Venclyxto is being developed by AbbVie and Roche.
Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients Medical Dialogues Bureau28 March 2020 4:45 AMUS: Genentech, a member of the Roche Group has announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind,...
Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia Medical Dialogues Bureau20 March 2020 4:30 AMBasel: Roche has announced that it is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled...
Roche Diagnostics India first private firm to get COVID-19 test approval Medical Dialogues Bureau20 March 2020 4:30 AMNew Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit,...
Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test Medical Dialogues Bureau15 March 2020 7:19 AMBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2...
Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer Medical Dialogues Bureau12 March 2020 6:42 AMCINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus...
Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeit Medical Dialogues Bureau22 Feb 2020 10:34 AMAmong the 24 participating companies are Amgen Inc, FedEx Corp, GlaxoSmithKline Plc, Novartis, AmerisourceBergen Corp , Sanofi ), Walgreens Boots...
FDA grants priority review to Roche's Tecentriq monotherapy as first-line treatment in certain lung cancer cases Medical Dialogues Bureau20 Feb 2020 8:50 AMBasel: Roche announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and...
Roche Alzheimers disease drug fails to meet primary goal Medical Dialogues Bureau11 Feb 2020 6:00 AMBasel: Roche, recently announced that the gantenerumab arm of Phase II/III DIAN-TU-001 study did not meet its primary endpoint in people who have an...
Granules India arm gets USFDA nod for generic version of Valcyte Medical Dialogues Bureau5 Feb 2020 9:43 AM Valganciclovir hydrochloride oral solution is bioequivalent to the reference listed drug product (RLD), Valcyte for Oral Solution, 50mg/mL, OF Roche...
Roche provides update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer MD bureau27 Jan 2020 8:52 AMBasel: Roche has announced that the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab) as an adjuvant (after surgery) monotherapy...
